Nearly half of treated patients had five years’ progression-free survival after transplant Related items from OnMedica New multiple sclerosis drug hailed as a 'landmark' A clinical review of multiple sclerosis High cost of unscheduled care for MS patients MS progression worse in patients who smoke GPs have little confidence in primary care neurology services |
No comments:
Post a Comment